Ex Vivo Immunization: A Strategy for Immunization Against SARS-CoV-2
Singh H, Nuthalapati P, Yendapalli P, Sahu D. Ex Vivo Immunization: A Strategy for Immunization Against SARS-CoV-2. 2024, 258-271. DOI: 10.1039/bk9781837672813-00258.Peer-Reviewed Original ResearchPeripheral blood mononuclear cellsNatural killer cellsCell-mediated immunityBlood mononuclear cellsEnhanced immune responseNaive lymphocytesDendritic cellsKiller cellsT cellsAntigen presentationB cellsMononuclear cellsImmune responseSARS-nCoV-2Human hostSignaling cascadesSARS-CoV-2Global pandemic coronavirus diseaseVirion particlesImmunityMass immunizationAdverse effectsCoronavirus 2Pandemic coronavirus diseaseNeuroinvasion by SARS-CoV-2 Influences the Prognosis of Neurological Disorders
Nuthalapati P, Ghanta M, Farran B, Chenchula S, Vedam V, Pukalendiran V, Amerneni K, Bhaskar L. Neuroinvasion by SARS-CoV-2 Influences the Prognosis of Neurological Disorders. 2024, 272-308. DOI: 10.1039/bk9781837672813-00272.Peer-Reviewed Original Research